Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,891.00
Bid: 1,887.00
Ask: 1,889.00
Change: 16.00 (0.85%)
Spread: 2.00 (0.106%)
Open: 1,897.00
High: 1,897.00
Low: 1,877.00
Prev. Close: 1,875.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

Mon, 27th Sep 2021 12:14

(Alliance News) - Stocks in London were in the green at midday on Monday, though easing from earlier highs, with Rolls-Royce shares leading the FTSE 100 on the back of a big contract win, while in the US Republicans dig in against President Joe Biden's multi trillion-dollar infrastructure bill.

The large-cap index was up 17.31 points, or 0.3%, at 7,068.77. The mid-cap FTSE 250 index was up 33.55 points, or 0.1%, at 23,642.37. The AIM All-Share index was up 5.00 points, or 0.4%, at 1,271.98.

The Cboe UK 100 index was up 0.2% at 702.40. The Cboe 250 was up 0.1% at 21,425.30. The Cboe Small Companies was 0.7% higher at 15,825.80.

In mainland Europe, the CAC 40 stock index in Paris was up 0.6% and the DAX 40 index in Frankfurt was up 0.8%.

US stock market futures were pointed mostly higher. The Dow Jones Industrial Average was called up 0.3% and the S&P 500 up 0.1%, but the Nasdaq Composite was called down 0.3%.

On the political front, US House Speaker Nancy Pelosi expressed confidence a massive infrastructure bill will pass this week but acknowledged it might not get a Monday vote as planned, with fellow Democrats warning critical work remains to meet the party's deadlines.

Democrats have been scrambling to hammer out a landmark plan to upgrade the nation's roads and bridges, but are also under immense pressure to finalise a USD3.5 trillion public investment package and fund the government to avert a looming shutdown - all by September 30.

The week is among the most critical of President Joe Biden's tenure, with opposition Republicans contesting his Build Back Better programme that would invest in climate change policy, lower childcare and education costs for working families and create millions of jobs.

Equipment rentals firm Ashtead Group was among the worst blue-chip performers, down 3.6%. Ashtead generates a bulk of its revenue in the US via its Sunbelt division.

IG Group's Chris Beauchamp commented: "Early gains for the FTSE 100 have been knocked back, but European markets are doing better and US futures look solid. The new week has started in a very different fashion to the last one, indices having staged an impressive recovery from last Tuesday's lows.

"China worries seem to have evaporated, or at least have dimmed in importance, and with the US once again talking about an infrastructure bill we seem to have a welcome return to some of the old themes that proved so fruitful for equity markets in the first half of the year."

In the FTSE 100, Rolls-Royce was the top gainer, up 10%, after the jet engine maker said its Rolls-Royce North America unit was selected by the US Air Force to provide the power plant for the Boeing B-52 Stratofortress. The stock was trading at its highest level in 18 months.

The agreement was signed under the Commercial Engine Replacement Program and is worth a potential USD2.6 billion.

As part of the deal, Rolls-Royce will build and test the F130 engines at its Indianapolis, Indiana, facility following the recent completion of a USD600 million investment in the manufacturing campus. The B-52 CERP win creates demand for 650 engines to be produced at the site.

Further, the Rolls-Royce F130 engine will replace the TF33-PW-103, which has powered the B-52 since the 1960s, and is projected to no longer be supportable beyond 2030. The B-52 original equipment manufacturer, Boeing, is responsible for integrating the engines onto the aircraft.

Shares in oil majors BP and Royal Dutch Shell 'A' and 'B' were up 2.8%. 3.1% and 3.3% respectively, tracking spot oil prices higher.

Brent oil was quoted at USD79.12 a barrel Monday at midday, up sharply from USD77.86 late Friday. The North Sea benchmark touched an intraday high of USD79.52 in early trade - its highest level since October 2018.

The spike in oil prices came amid a petrol crisis which has seen panic-buying in at least half of local stations in the UK.

UK Prime Minister Boris Johnson is said to be considering whether to call in soldiers to deliver fuel to petrol stations as pumps ran dry after days of panic buying.

Emergency measures were triggered on Sunday evening, with Business Secretary Kwasi Kwarteng choosing to suspend competition laws for the fuel industry to allow suppliers to target filling stations running low.

Multiple reports suggested that Johnson on Monday will mull whether to follow that by taking the drastic step of sending in the army to drive oil tankers as "frenzied buying" added to fuel supply issues caused by a lack of HGV drivers.

Prudential was up 2.3% after the insurer said it expects to raise HKD18.5 billion, about USD2.37 billion, from its Hong Kong share offering. Its Hong Kong-listed shares ended up 2.8% to HKD151.90.

The new shares will be priced at HKD143.80 each, equivalent to GBP13.52. That price was first reported by Bloomberg News on Friday last week. Earlier last week, Prudential had said the shares would be sold for a maximum of HKD172 each.

Hikma Pharmaceuticals was up 1.1% after the generic drugmaker said it has agreed to buy Carlsbad, California-based injectables supplier Custopharm for USD375 million.

Hikma said the acquisition complements its own injectable product portfolio and pipeline, adding 13 approved products and additional pipeline products. The company expects the acquisition to generate annual revenue of over USD80 million and for the acquisition to be accretive to Hikma's Injectables operating margin.

Conversely, United Utilities was down 1.2%, despite issuing an upbeat trading update. The water company said trading has been in line with expectations during its first half, with earnings set to climb despite the water company facing inflationary pressures.

In the FTSE 250, Cineworld Group was the best performer, up 12%, ahead of the release of the latest James Bond film, 'No Time To Die', from midnight on Wednesday.

The film, which is Daniel Craig's final outing as the eponymous superspy, has been postponed three times and seen strong demand in pre-booked ticket sales.

Smaller picture house Everyman Media Group was up 4.1%.

IWG was up 5.6% after Sky News reported on Sunday that Chief Executive Mark Dixon is exploring breaking up the office provider into several distinct companies.

Dixon is looking at options including a US listing for Worka, IWG's app that allows customers to book office space. The listing could be through an initial public offering or a merger with a special purpose acquisition company, Sky said, citing insiders.

Under the plans being considered, IWG's owned-property unit would be separated from its franchising business, according to the report.

The pound was quoted at USD1.3700 at midday on Monday, higher from USD1.3670 at the London equities close Friday.

The euro was priced at USD1.1705, lower from USD1.1710 in the wake of the German election results.

Four German political parties were positioning themselves to enter coalition talks on Monday, just hours after a final vote count showed a narrow victory for the centre-left Social Democrats (SPD) over the country's conservative alliance.

The SPD captured 25.7%, its best result in years, while the conservative CDU/CSU bloc of the outgoing chancellor, Angela Merkel, fell to a record low of 24.1% after her four consecutive terms in office. Both main candidates to be the next German chancellor, Olaf Scholz of the SPD and Armin Laschet of the Christian Democrats, say they want to form the next government.

Scholz has a better chance of doing so, but the German constitution does provide for the party with the second-largest vote share to head a government.

Analysts at ActivTrades said: "The euro has barely moved against the US dollar during early Monday trading. The victory of the centre left SPD in the German general election, albeit by a very narrow margin, which will require a coalition with other parties, doesn't in essence change much in terms of Germany's stance within the European context. Observers predict a protracted period of negotiations between the winning Social Democrats and their potential coalition partners, that could take weeks or perhaps even months.

"In the meantime, the current government will remain in place, but even after a new executive is formed it is very unlikely that political events in Europe's largest economy will dramatically influence the performance of the single currency, as any of the potential coalition scenarios will be benign from an EU standpoint."

Against the yen, the dollar was trading at JPY110.95 at midday, up from JPY110.73 late Friday.

Gold stood at USD1,758.12 an ounce early Monday, higher against USD1,751.33 late Friday.

A quiet economic calendar on Monday has US durable goods orders at 1330 BST.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
24 Feb 2022 10:31

TOP NEWS: Hikma Pharmaceutical records revenue growth and lifts payout

(Alliance News) - Hikma Pharmaceutical PLC on Thursday reported full-year revenue growth on a "strong" performance by its three business segments and lifted its shareholder payout.

Read more
24 Feb 2022 07:58

Hikma Pharmaceutical delivers year of 'solid growth' and 'strategic momentum'

(Sharecast News) - Drugmaker Hikma Pharmaceutical said on Thursday that it had delivered another successful year of "solid growth and continued strategic momentum", with both revenue and operating profits improving year-on-year.

Read more
24 Feb 2022 07:50

LONDON MARKET PRE-OPEN: Share buybacks for Lloyds Banking and Hikma

(Alliance News) - Stock prices in London are seen opening sharply lower, with the FTSE 100 called down almost 200 points, amid fear of a full-scale war in eastern Europe after Russia announced the beginning of a military operation in Ukraine.

Read more
17 Feb 2022 16:08

UK earnings, trading statements calendar - next 7 days

Friday 18 February  
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
TBC Bank Group PLCFull Year Results
Monday 21 February 
Bank of Cyprus Holdings PLCFull Year Results
Dechra Pharmaceuticals PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Tristel PLCTrading Statement
Wilmington PLCHalf Year Results
Tuesday 22 February 
Antofagasta PLCFull Year Results
Bank of Georgia Group PLCFull Year Results
Benchmark Holdings PLCQ1 Results
Blancco Technology Group PLCHalf Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Coca-Cola HBC AGFull Year Results
Hargreaves Lansdown PLCHalf Year Results
HSBC Holdings PLCFull Year Results (at 0400 GMT)
InterContinental Hotels Group PLCFull Year Results
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Synectics PLCFull Year Results
Transense Technologies PLCHalf Year Results
Wednesday 23 February 
Aston Martin Lagonda Global Holdings PLCFull Year Results
Barclays PLCFull Year Results
Capital & Counties Properties PLCFull Year Results
CAP-XX LtdHalf Year Results
Georgia Capital PLCFull Year Results
International Personal Finance PLCFull Year Results
Irish Residential Properties REIT PLCFull Year Results
Metro Bank PLCFull Year Results
Hochschild Mining PLCFull Year Results
Photo-Me International PLCFull Year Results
Rio Tinto PLCFull Year Results
Seraphim Space Investment Trust PLCHalf Year Results
Ted Baker PLCTrading Statement
Unite Group PLCFull Year Results
Thursday 24 February 
Anglo American PLCFull Year Results
BAE Systems PLCFull Year Results
Centrica PLCFull Year Results
Conduit Holdings LtdFull Year Results
Derwent London PLCFull Year Results
Drax Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Inchcape PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Rathbone Group PLCFull Year Results
Ricardo PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
St James's Place PLCFull Year Results
Tremor International LtdFull Year Results
WPP PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
9 Feb 2022 09:48

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

Read more
3 Feb 2022 09:12

Hikma completes acquisition of Teligent's Canadian assets

Hikma completes acquisition of Teligent's Canadian assets

Read more
17 Jan 2022 09:01

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 09:00

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 07:49

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

Read more
17 Jan 2022 07:08

Hikma buys Teligent Canadian assets for $47.75m

(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for Chapter 11 bankruptcy last year.

Read more
10 Jan 2022 07:44

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

Read more
10 Jan 2022 07:24

Hikma launches new US injectables unit

(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compounding business in the US.

Read more
21 Dec 2021 15:55

Arecor flags milestone payment from Hikma in first half of next year

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.

Read more
9 Dec 2021 09:25

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Read more
9 Dec 2021 08:32

Hikma strikes exclusive license agreement with Richter for denosumab

(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's denosumab products in the US.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.